(Reuters) -Australian biotech giant CSL on Tuesday said executive Ken Lim will take over as chief financial officer, starting October 7, as Joy Linton prepares to retire.

Lim’s appointment follows his role as chief strategy officer, a position he has held since August 2023, and highlights his decade-long tenure in senior executive roles at the company, CSL said in a statement.

Linton, who is retiring the same day, was named finance chief in 2020. She previously served as CFO of global health insurance company Bupa.

CSL, headquartered in Melbourne, is a global biotechnology firm specializing in vaccines, therapeutics and diagnostics.

(Reporting by Adwitiya Srivastava in Bengaluru; Editing by Sahal Muhammed)

See Full Page